JAF Capital Becomes Hydration Pharmaceuticals’ Substantial Holder With 5% Stake
JAF Capital Pty Ltd became a substantial holder in Hydration Pharmaceuticals Co Ltd, reporting a direct interest in just over 27 million ordinary shares, equivalent to 5.05% of voting power. The notice records an acquisition of just over 8 million shares on 23 October.
Closing price · 2026-10-27: $0.003 · +50.00%